Skip to main content
Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
26.88
+0.48 (1.82%)
Nov 21, 2024, 1:50 PM EST - Market open

Celldex Therapeutics Revenue

Celldex Therapeutics had revenue of $3.19M in the quarter ending September 30, 2024, with 110.35% growth. This brings the company's revenue in the last twelve months to $9.98M, up 128.55% year-over-year. In the year 2023, Celldex Therapeutics had annual revenue of $6.88M with 192.02% growth.

Revenue (ttm)
$9.98M
Revenue Growth
+128.55%
P/S Ratio
160.95
Revenue / Employee
$62,350
Employees
160
Market Cap
1.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.88M4.53M192.02%
Dec 31, 20222.36M-2.29M-49.32%
Dec 31, 20214.65M-2.77M-37.30%
Dec 31, 20207.42M3.85M107.61%
Dec 31, 20193.57M-5.97M-62.54%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.98B
Clover Health Investments 2.12B
Integra LifeSciences Holdings 1.56B
GoodRx Holdings 790.39M
10x Genomics 629.74M
NovoCure 577.74M
AtriCure 447.57M
Immunocore Holdings 296.31M
Revenue Rankings

CLDX News

More News